Floatz logo

TECHNETIUM TC 99M PYROPHOSPHATE

Amyloid Cardiomyopathy, Transthyretin-Related

Mathew S. Maurer, MDSmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Amyloid Cardiomyopathy, Transthyretin-Related cohort.

Asset / SponsorPhaseRating
Acoramidis
Eidos Therapeutics, a BridgeBio company
Phase 3BB
Technetium Tc-99m Oxidronate
Mathew S. Maurer, MD
D

Same molecule, other indications

TECHNETIUM TC 99M PYROPHOSPHATE is also rated in:

amyloidosisDormant
CC
Indicative ·
43 / 100
View asset →
aortic valve stenosisDormant
CC
Indicative ·
43 / 100
View asset →
Transthyretin AmyloidosisDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →